tirzepatide patent owner Is There a Generic Tirzepatide? Patents & Options BPI challenges Eli Lilly's patent

Because the formulations differ

In the SURMOUNT-1 clinical trial, participants on the highest dose of Mounjaro (15 mg) lost an average of 22.5% of their body weight over 72 weeks 1

The study, which was published this week in the Lancets eClinicalMedicine journal, used electronic health records from TriNetX covering more than 100,000 patients from the start of 2017 to May of 2021

And of course, physical comfort during sex plays a role

we attempted to negate any operator bias by randomizing the data and having each data point processed three times by the same research staff member (SEW)

Another option to look into are the Special Needs Plans (SNPs) offered by some Medicare Advantage companies